Apply for unlock_

EXIT071 develops innovative technology for the analysis of exosomes in therapeutics and diagnostics.

EXIT071 is dedicated to staying at the forefront of emerging technologies and providing innovative solutions for exosome research. In this way, they aim to continuously offer groundbreaking solutions to their customers.

Contact information
  • Galileiweg 8 2333 BD, Leiden

Other startups & participants

View all
AromAB
AromAb is developing a new technology to purify antibodies for biological drugs more quickly and che...

Read more

Aziflu
Aziflu is developing new antiviral drugs against influenza (flu). Their focus is on treatments that ...

Read more

CaraOmics
CaraOmics is developing a platform for building “clinical digital twins”: digital models of patients...

Read more

Omivera
Omivera is developing a platform called CellEKT that allows pharmaceutical researchers to better mea...

Read more

Gateway Bio
Gateway Bio is a biotech startup that aims to address antibiotic resistance with a new type of drug ...

Read more

QDiaMon
QDiaMon is a healthtech startup developing a wearable device that can measure multiple biomarkers fr...

Read more

HeartSmart
HeartSmart is a biotech startup developing a human heart tissue model to improve heart failure drug ...

Read more

Radigene
Radigene develops a novel imaging technology that makes therapeutic cells visible inside the body. B...

Read more

ONEIRA
Oneira is a biotech startup working to improve cancer treatments by being able to better direct ther...

Read more

Vindi Biosystems
Vindi Biosystems is developing a wearable device for continuous, real-time monitoring of disease ass...

Read more

SBMatrices
SBMatrices is making a synthetic, animal-free gel with Fybrix in which you can grow cells for resear...

Read more

GlycoDiagnostics
GlycoDiagnostics aims to detect people with potentially dangerous liver disease early on, before it ...

Read more